Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Review Paper

Comparison of Environmental and Genetic Factors for Parkinson’s Disease between Chinese and Caucasians

Chan D.K.Y.a · Cordato D.b · Bui T.a · Mellick G.c · Woo J.d

Author affiliations

aDepartment of Age Care and Rehabilitation (UNSW, UWS), bNeurology Department, Bankstown Health Service, Bankstown, and cPrincess Alexandra Hospital, University of Queensland, Woolloongabba, Australia; dChinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong

Corresponding Author

Prof. Daniel Kam Yin Chan

Department of Age Care and Rehabilitation

Bankstown Health Service, Lock mail bag 1600

Bankstown, NSW 2200 (Australia)

Tel. +61 2 9722 7558, Fax +61 2 9722 8275, E-Mail daniel.chan@swsahs.nsw.gov.au

Related Articles for ""

Neuroepidemiology 2004;23:13–22

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


This review paper compares the differences in prevalence, and environmental and genetic risk factors for Parkinson’s disease between Chinese and Caucasian subjects. Comparison of age-specific prevalence between Chinese people and Caucasians suggests that the prevalence is lower in the Chinese (at least in the past), although the prevalence rate in China appears to be rising. Distinctions in environmental risk factors and genetic factors are discussed. The difference in prevalence may be due to distinctions in environmental and genetic risk factors as well as the complex interaction between these environmental and genetic factors, although discrepancies in methodology for prevalence surveys can also be an explanation.

© 2004 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Review Paper

Published online: January 23, 2004
Issue release date: January – April

Number of Print Pages: 10
Number of Figures: 1
Number of Tables: 3

ISSN: 0251-5350 (Print)
eISSN: 1423-0208 (Online)

For additional information: http://www.karger.com/NED

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.